The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear

R F Xie1, P Hu, W Li

  • 1The Blood Engineering Laboratory, Shanghai Blood Center, Shanghai, China.

Vox Sanguinis
|October 22, 2013
PubMed
Abstract

Insights

Platelet-derived microparticles (PMPs) carrying sCD40L accumulate in stored platelet concentrates. These PMPs prime neutrophil respiratory bursts, potentially contributing to transfusion-related acute lung injury (TRALI).

Area of Science:

  • Hematology
  • Immunology
  • Transfusion Medicine

Background:

  • Platelet-derived microparticles (PMPs) and inflammatory mediators accumulate during platelet concentrate storage.
  • These accumulated substances may trigger adverse transfusion events.
  • Transfusion-related acute lung injury (TRALI) is a potential complication.

Purpose of the Study:

  • To investigate the role of PMPs in priming polymorphonuclear neutrophil (PMN) respiratory burst.
  • To determine if PMP-primed PMN activity is linked to TRALI.
  • To analyze the accumulation of PMPs and soluble CD40 ligand (sCD40L) during apheresis platelet concentrate (A-PLT) storage.

Main Methods:

  • PMPs were isolated from A-PLTs via centrifugation.
  • PMP counts were determined by flow cytometry.
  • Western blotting and ELISA were used to detect sCD40L within PMPs.
  • PMN respiratory burst activity was measured by hydrogen peroxide production.

Main Results:

  • PMP counts increased significantly with storage duration (1.7-fold by day 3).
  • sCD40L levels increased in PMP fractions from stored A-PLTs.
  • PMPs effectively primed fMLP-activated PMN respiratory burst.
  • This priming activity was partially inhibited by anti-CD154 antibody and filtration.

Conclusions:

  • Platelet-derived microparticles carrying sCD40L accumulate in A-PLTs during storage.
  • These PMPs prime the PMN respiratory burst.
  • This PMP-mediated priming may be a contributing factor to TRALI.